Tag: FDA

Top Medical News Stories of 2011

1. FDA Calls for Simvastatin Limits The FDA played a role in most of this year’s top news stories, starting with a June 8 recommendation that physicians restrict prescribing high doses of the cholesterol medication simvastatin (Zocor, Merck) because of a risk for muscle damage. The FDA drug safety communication states that physicians should limit using the…

Read More

FDA Says Pharmacies Can Still Compound Generic Makena

Pharmacies can continue to compound generic hydroxyprogesterone caproate for reducing the risk for preterm delivery despite warnings from KV Pharmaceutical — which sells a costly, branded version of the drug — not to do so, the US Food and Drug Administration (FDA) announced today. On February 3, the FDA approved KV Pharmaceutical’s Makena, an injectable form of hydroxyprogesterone…

Read More
© 2021 Neera Bhatia MD OBGYN. All Rights Reserved. San Antonio Website Design & Development - Backyard Studios